Redigerer Arcturus COVID-19-vaksine

'''Arcturus COVID-19-vaksinen''', også kjent som '''ARCT-021''' og '''LUNAR-COV19''', er en [[COVID-19-vaksine]]<nowiki></nowiki>kandidat utviklet av [[Arcturus Therapeutics]].

== Utvikling ==
Arcturus Therapeutics pinngikk i partnerskap med Singapores [[Duke–NUS Medical School]] for å utvikle en COVID-19 -vaksine<ref>{{cite web | vauthors = Teo J | date = 15. april 2020 |title= Coronavirus: Clinical trials for Singapore's vaccine project could start in August |url=https://www.straitstimes.com/singapore/health/clinical-trials-for-singapores-vaccine-project-could-start-in-august |website=[[The Straits Times]] |access-date=27. april 2020}}</ref>. Selskapet inngikk også partnerskapsavtale med [[Catalent]] for produksjon av Arcturus COVID-19 [[mRNA-vaksine]]-kandidat.<ref>{{cite news | vauthors =  Stanton D | date = 6. mai 2020 |title=With Arcturus, Catalent bags another COVID project |work=Bioprocess Insider |url=https://bioprocessintl.com/bioprocess-insider/facilities-capacity/with-arcturus-mrna-project-catalent-bags-another-covid-vaccine-deal/|language=en-US|access-date=2020-05-08}}</ref>

== Klinisk forskning==
=== Fase I-II ===
Klinisk testing begynte i juli 2020. Den 4. januar 2021 innleder Arcturus Therapeutics fase-2-utprøvingene.<ref>{{cite news |title=Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the |url=https://www.bloomberg.com/press-releases/2021-01-04/arcturus-therapeutics-receives-fda-allowance-to-proceed-with-phase-2-study-of-arct-021-lunar-cov19-vaccine-candidate-in-the |access-date=17. januar 2021 |publisher=Bloomberg |date=4. januar 2021}}</ref>

== Avtaler ==
Arcturus inngikk avtaler for utvikling og forsyninger med [[Economic Development Board|Economic Development Board of Singapore]] og med forsyninger med det [[israel]]ske helseministerium.<ref>{{cite news | vauthors = Anwar N |title=Singapore’s co-developed vaccine candidate is in ‘good shape’ for delivery in 2021 |url=https://www.cnbc.com/2020/11/27/singapore-arcturus-coronavirus-vaccine-candidate-on-track-for-2021-delivery.html |access-date=18. mars 2021 |publisher=CNBC |date=26. november 2020}}</ref><ref>{{cite news | vauthors = Cheok M, Mookerjee I |title= Singapore Will Get First Claim to Any Successful Arcturus Vaccine |url=https://www.bloomberg.com/news/articles/2020-08-04/singapore-to-get-first-claim-to-any-successful-arcturus-vaccine |access-date=18. mars 2021 |publisher=Bloomberg |date=5. august 2020}}</ref>

== Referanser ==
<references />


[[Kategori:Covid-19-vaksiner]]

[[Kategori:RNA-vaksiner]]